Servicios
Servicios
Buscar
Idiomas
P. Completa
Evaluation of Staphylococcus aureus resistance profile isolated from nursing students in an institution of higher education
Carolina Marino; Juliana Tramontini Marcatto; Carolina Yumi Gushiken;
Carolina Marino; Juliana Tramontini Marcatto; Carolina Yumi Gushiken; Rodrigo Santos Lima; Daniela Vanessa Moris; Marcus Vinicius Pimenta Rodrigues
Evaluation of Staphylococcus aureus resistance profile isolated from nursing students in an institution of higher education
Avaliação do perfil de resistência de staphylococcus aureus isolados de estudantes de enfermagem de uma instituição de ensino superior
Acta Scientiarum. Health Sciences, vol. 38, no. 2, pp. 145-152, 2016
Universidade Estadual de Maringá
resúmenes
secciones
referencias
imágenes

Abstract: Staphylococcus aureus causes a large variety of infections, where many of them are acquired in the hospital environment. A significant part of the population is a nasal carrier of this type of microorganism. The present study evaluated the nasal colonization by S. aureus, identifying its resistance profile in nursing students from a private educational institute of higher education. Nasal swab samples were collected and identified for S. aureus. Moreover, an antibiogram assay was performed, followed by the search for ermA and ermC genes using PCR. Sixty-two students were included and we isolated 20 positive samples (32,5%) for S. aureus. For the phenotypic profile, 30% were found to be resistant to Erythromycin and 10% to Oxacillin and Cefoxitin. For the D-test in the genotypic profile, 25% presented mecA gene (MRSA), 5% of ermA gene, 35% of ermC gene and 10% with ermC and mecA genes. These data reinforce the necessity of monitoring bacterial colonization in hospital environment, which are potentially resistant in health professionals.

Keywords:colonizationcolonization, betalactam betalactam, macrolides macrolides, MRSA MRSA, MLSb MLSb.

Resumo: Staphylococcus aureus causa uma grande variedade de infecções, muitas delas adquiridas no ambiente hospitalar. Uma parcela significativa da população é carreadora nasal desses micro-organismos. O presente trabalho avaliou a colonização nasal por S. aureus identificando seu perfil de resistência em estudantes de enfermagem de uma instituição privada de ensino superior. Foram coletadas e identificadas amostras de swab nasal para S. aureus e realizado o antibiograma e a detecção por PCR dos genes mecA, ermA e ermC. Foram incluídos 62 alunos e isoladas 20 amostras (32,3%) positivas para S. aureus, no perfil fenotípico, 30% apresentaram resistência à Eritromicina e 10% para Oxacilina, Cefoxitina e para o teste D, no perfil genotípico 25% apresentaram gene mecA (MRSA), 5% do gene ermA e 35% do gene ermC, e 10% com genes ermC e mecA. Esses dados reforçam a necessidade de monitoramento de colonização por bactérias potencialmente resistente em profissionais da saúde.

Palavras-chave: colonização, betalactâmicos, macrolídeos, MRSA, MLSb.

Carátula del artículo

Enfermagem

Evaluation of Staphylococcus aureus resistance profile isolated from nursing students in an institution of higher education

Avaliação do perfil de resistência de staphylococcus aureus isolados de estudantes de enfermagem de uma instituição de ensino superior

Carolina Marino
Universidade do Oeste Paulista, Brasil
Juliana Tramontini Marcatto
Universidade do Oeste Paulista, Brasil
Carolina Yumi Gushiken
Universidade do Oeste Paulista, Brasil
Rodrigo Santos Lima
Universidade do Oeste Paulista, Brasil
Daniela Vanessa Moris
Universidade do Oeste Paulista, Brasil
Marcus Vinicius Pimenta Rodrigues
Universidade do Oeste Paulista, Brasil
Acta Scientiarum. Health Sciences, vol. 38, no. 2, pp. 145-152, 2016
Universidade Estadual de Maringá

Received: 08 October 2015

Accepted: 30 March 2016

Introduction

Staphylococcus aureus can cause a wide variety of infections, where many of them are acquired in the hospital environment. The high transmissibility, the elevated pathogenic potential and the possibility of resistance to multiple antibiotics are items that contribute to staphylococcal infections in hospitals and other health-care services. The majority of the population are carriers of these bacteria, however they do not present any infection symptoms. The main niches are the nasal mucosa and perineum. This carrier pattern, where bacterial reproduction is observed without immunological interaction or

clinical disease is called ‘colonization’. Either the colonized individual or those who present infection are able to transmit S. aureus through direct or indirect contact. This phenomenon, called ‘cross transmission’ presents increased dynamics in the hospital environment and this fact has a significant contribution to the inherent gravity of hospitalized individuals, to the invasive procedures executed in the hospital, to the use of antibiotics and the occurrence of ‘understaffing’ (in other words, a low number of professionals providing assistance to a large quantity of patients) (Muto et al., 2003).

Several virulence factors are responsible for the symptoms and the gravity of infections caused by S. aureus. The cells of S. aureus are composed by certain superficial components, including adhesion molecules, peptidoglycan and protein A, which allow these microrganisms to evade the host immune system (Ladhani, Joannou, Lochrie, Evans, & Poston, 1999; Dinges, Orwin, & Schlievert, 2000; Foster, 2005). They also produce several extracellular enzymes such as catalase, nuclease, hyaluronidase, lipase, and fibrinolysin that hydrolyze proteins and other molecules, generating useful nutrients for S. aureus and at the same time facilitating the spread of these bacteria to the tissues (Archer & Climo,1998). Some strains are even capable of producing one or more toxins, which can be generally classified into two groups, the active agents in membranes, comprising toxins alpha, beta, delta, gamma and Panton-Valentine leukocidin (pvl, LukE-lukD genes), designated as PVL, and the toxins with superatingen activity (SAgs), including the family of pyrogenic toxins (PTs), which are the staphylococcal-entero-toxins (SEs), toxic shock syndrome toxin (TSST-1) and the family of exfoliative toxins (ETs) (Bohach, Fast, Nelson, & Schlievert, 1990). Some of the genes linked to these toxins can often be transported by mobile genetic elements, such as phages and pathogenicity islands (SaPIs), which are potentially mobile parts of DNA with different sizes, gene encoders associated with virulence, that are transferred horizontally among the strains, (for example the genes responsible for codifying enterotoxins B and C, and the toxic shock syndrome toxin)(Hanssen & Sollid, 2006). The importance of S. aureus as a pathogen is found in the combination of virulence mediated by its toxins, its invasive characteristic, its resistance profile to antibiotics (Le Loir, Baron, & Gautier, 2003) and the dissemination of isolates resistant to antibiotics utilized in clinical practice, which is a limiting factor to the treatment of staphylococcal infections (Fitzgerald, Sturdevant, Mackie, Gill, & Musser, 2001). An important mark in staphylococcal therapy was the appearance of Methicillin Resistant Staphylococcus aureus (MRSA), being noticed in the last decades a gram-positive pathogen predominant in hospital infections. It is estimated that this bacteria is involved in more than 50% of staphylococcal infections acquired in health-care services (Barrett, 2005; Deresinski, 2005; Finch, 2006). The MRSA are resistant to all beta-lactam antibiotics (Penicillin, Cephalosporin, Carbapenems and Monobactams), because they express a receptor with low affinity to these antibiotics. These antibiotics link themselves to constitutive bacterial enzymes, which participate in the synthesis of the cell wall and the Penicillin Binding Proteins (PBPs), avoiding its correct function. MRSA has the capacity of synthesizing a variant of PBP2 called PBP2A, keeping its physiological function, but with low affinity to beta-lactams (Ito, Okuma, Ma, Yuzawa, & Hiramatsu, 2003; McCulloch, 2006). The gene that codifies the protein PBP2a, called mecA, along with its regulator gene is found in a mobile genetic element, sthaphylococcal cassette chromosome mec (SCCmec) (Enright et al., 2002). To date, eleven (I-XI) SCCmec types have been fully identified by the determination of mec (A, B, C1, C2 and D) and ccr (i.e. ccrAB1 to ccrAB5 and ccrC) complexes (Hiramatsu, Cui, Kuroda, & Ito, 2001; McCulloch, 2006; Mkrtchyan, Xu, & Cutler, 2015). Some of these genes are carriers of determinant genes to multiple antibiotics, besides the Macrolides, Lincosamides, Streptogramins, Aminoglycosides and Tetracyclines. Thus when a bacterial cell acquires these SCCmec genes at once, it acquires a phenotype of multi-resistance (Ito et al., 2003; McCulloch, 2006).

Nevertheless, the prevalence in the isolation of MRSA strain varies between 40 to 80% in Brazil, generally presenting resistance to Aminoglycosides, Chloramphenicol, Lincosamides, Macrolides, Quinolones, Sulfamethoxazole – Trimethoprim and Tetracyclines with a high susceptibility only to Rifampicin and Glycopeptides, therefore the demand for a glycopeptide in this type of infection is high (Oliveira, Faria, Levyand, & Mamizuka, 2001; Gardella et al., 2005). Studies regarding the geographic dissemination of multiresistant epidemic clones of S. aureus in Brazil demonstrated that tested isolates presented the same phenotype of resistance to Methicillin, and the majority of these isolates (> 70%) were multiresistant to at least 9 antibiotics (Vivoni et al., 2006). Furthermore the clones were largely disseminated in several areas of Brazil. The presence of a Brazilian endemic clone of MRSA (BEC) in many hospitals in South America and Europe has also been described (Sader, Pignatari, Hollis, Leme, & Jones, 1993; Pannuti & Grinbaum, 1995). The infections caused by MRSA are associated with considerable morbidity and mortality, being also one of the most expensive treatments in comparison to other infections. This considerable increase in the expenses related to the management of these infections is due to the prolonged hospitalization, the increase of isolation procedures, besides the additional medical care and the financial overload in secondary therapy. The high impact of MRSA upon the morbidity, mortality and expenses has been largely reported in the United States and among European countries (Barrett, 2005; Finch, 2006). Until 90’s, MRSA used to be isolated only in hospital environments. However, the transmission of MRSA in the community has been reported in recent years (Rajana, Schoenfelderb, Ziebuhrb, & Gopal, 2015). In this context, isolates were identified with specific genetic characteristics, called CA-MRSA (Community-acquired Methicillin – Resistant Sthaphylococcus aureus). A large dissemination of CA-MRSA in the community is feared, which would turn innocuous any measurement control for MRSA in hospitals (Vivoni et al., 2006). In general, the epidemic occurrences of MRSA receive a higher attention. This fact is explained by the abrupt increase of morbidity and mortality by hospital infections in the presence of outbreaks. Outbreaks and epidemics can have devastating consequences, but they are more easily controlled, once the causative factors have been identified. On the other hand, endemic profiles are hard to be managed. Effective interventions to reduce the endemic rates of MRSA require a large review of work process and normalization of procedures for the identification and isolation of carriers (Muto et al., 2003). It is necessary to emphasize that colonization by MRSA is hard to eradicate. Furthermore, studies have pointed that individuals previously colonized are more susceptible to subsequent colonization during hospitalization and even after hospital discharge (Corso, Sanches, Sousa, Rossi, & Lencastre, 1998; Seas et al., 2006). The phenotypic test method of double disc diffusion (D test) provides an inducible resistance for the gene erm, and it is demonstrated by the narrowing of the inhibition zone around the Clindamycin disc and by the side of the Erythromycin disc, featuring the resistance to Erythromycin inducible to Clidamycin (iMLSb) (Teixeira et al., 1995). Clindamycin is considered an alternative drug for the treatment of infections caused by S. aureus in the cases of Penicillin intolerance or resistance to Methicillin, inhibiting the production of toxins and virulence factors through the inhibition of protein synthesis. There are two mechanisms, which can result in the resistance to this antibiotic, firstly the macrolide flux controlled by msrA and the second is the modification of the binding site in the ribosome, controlled by the erm gene (Erythromycin Ribosomal Methylase).The ribosomal methylation is responsible for cross-resistance to Macrolides, Lincosamides and Streptogramins B, called MLSb phenotype in staphylococci ermA and ermC. These are genes related to the expression of this phenotype, making the modification in the binding target due to the

methylation of residue A2058, locatedin the V domain of 23s (Naimi et al., 2001; Pereira & Cunha, 2009). S. aureus synthesizes ribosomal methylase, which is encoded by the erythromycin resistance gene or another methylases (ERM). With methylation, the binding site of Macrolide - Lincosamide Streptogramin B is changed. The main methylases genes encoded by S. aureus are ermA, ermB and ermC (Heshiki, Quesada, Heshiki, Joaquim, & Brandão, 2002). The resistance of MLSb can be expressed in a constitutive and inductive form, the first presents cross-resistance to the antibiotics MLSb, and the second (MLSbi) presents in vitro resistance to macrolides (Naimi et al., 2001).

Some clinical failures related to mutation of Clindamycin resistance have been reported, however there is no chance of resistance appearing during treatment with Clindamycin. The causative factors for resistance are the frequency of resistance mutation, size of bacterial inoculum and type of infection. The understanding regarding the epidemiology of colonization/infection by S. aureus has important implications to control measures. In this way, it is necessary to document the dissemination of isolates and identify the resistance factors related to these isolates. These are the central aims of this project. The present study also aims to identify the prevalence of molecular factors linked to the resistance to macrolides and beta-lactams in S. aureus strains isolated from the nasal mucosa in nursing students from a private institution of higher education in the State of São Paulo.

Material and methods
Characterization and recruitment of sample

The present study was registered and approved by the protocol of Brazil platform nº 14274613.6.0000.5515.

The study included students that started the nursing course in 2012 and in the first period of 2013 and who agreed to participate in the project by signing the Informed Consent Form. Students who presented any sign of infection of upper airways and that used antibiotics up to seven days prior to the collection date were not included in the study. All the positive cultures for Staphylococcus aureus from nasal mucosa in students regularly enrolled in the nursing course were analyzed. Strains of S. aureus ATCC 25923 were used as a reference, while for quality control strains of S. aureus ATCC 33591, S. aureus 29213 and S. aureus 19095 were used. All the samples were identified and tested for the sensitivity to Erythromycin, Clindamycin, Oxacillin and Cefoxitin. All the samples were classified into 2 groups: Group I, new students in the course or those enrolled in the course up to 1 year of study, and group II: =, students enrolled in the course over 1 year of study.

Statistical analysis

The percentage of the resistance frequencies related to the data was analyzed in a descriptive form. The G test was used for the comparison of the proportions among the samples of resistant S. aureus and the others sensitive to antibiotics and the duration of the study. The Fisher’s exact test was used for the comparison of the proportions among the samples of resistant S. aureus sensitive to antibiotics and the fact of working or not in hospitals. The significance level for all the tests was defined as p < 0.05. The analysis was made using the BioStat 5.3 program.

Procedures and research tools

Samples from nasal mucosa were collected from nursing students. Sterile ‘swabs’ wet with previously sterilized saline were used during the collection of the material. The ‘swab’ was introduced in the anterior nasal mucosa during the collection procedure, executing delicate circle movements 3 times. After collection, all the materials were placed inside of dry sterile tubes and immediately sent to the Microbiology Laboratory for inoculation in Mannitol-Salt Agar plates, a selective media for Staphylococcus. After incubating in 37ºC for 24 hours, the samples were submitted to the identification procedure of the isolates.

The microorganisms that grew in the culture plates were submitted to Gram staining, in order to observe morphology and specific coloration. After the confirmation of these characteristics, catalase and coagulase tests were carried out in tubes as recommended. Additional tests such as Maltose, Trehalose, Mannitol and Polymyxin B were performed for the differentiation from other species of coagulase positive Staphylococcus.

Antimicrobial susceptibility tests were performed for all isolates obtained through the drug diffusion in agar technique with impregnated discs according to the criteria recommended by Clinical Laboratory Standards Institute (CLSI, 2011). For the preparation of the inocula, cultures were used in BHI broth preincubated for 4 to 6 hours and then adjusted to 0.5 MacFarland scale. The drugs used were: Oxacillin, Cefoxitin, Clindamycin and Erythromycin. Once the density of the inoculums was adjusted, the inoculation was carried out

through the use of sterile ‘swab’ on the surface of Mueller Hinton Agar, followed by the application of discs impregnated with the drugs. The plates were incubated at 35ºC for 24 hours and the antimicrobial activity measured by the inhibition zone diameter through interpretation based on the rules established by the CLSI (2011). For genotypic determination, the polymerase chain reaction (PCR) was performed, which amplified mecA, ermA and ermC genes as described by Coutinho et al. (2010). The presence of the fragments was assessed by carrying out gel electrophoresis in 1.7% agarose in 1X TBE Buffer (90 mM Tris, 90 mM Boric acid, 2 mM EDTA pH 8.0) stained with Ethidium Bromide 0.5 mg mL-1. The amplified products were compared with a 100 bp marker (Amersham Pharmacia Biosciences Inc.) and then visualized and photographed under ultraviolet light.

Results and discussion

Among the students from the first to the third period, 25, 20 and 26 samples were obtained respectively (Figure 1A). From a total of 71 students, 35.2% work in hospitals, where 20, 30 and 53.8% of students are from the first, second and third period, respectively. In addition, 78.9% of students were female and 21.1% male. From the total of students, 6 were presenting flu or cold symptoms on the day of collection and 3 were taking antibiotics, thus they were not included in the study, leaving 62 students in the sample.

The 62 samples were submitted to the identification process, and 20 samples (32.3%) were found to be positive for Staphylococcus aureus. In the assessment of positive samples for S. aureus, it was observed that 30% of the samples presented resistance to Erythromycin, no positive sample resistant to Clindamycin, 1 sample with intermediate profile, 10% of samples resistant to cefoxitin and 10% resistant to oxacillin.

In addition, 10% of the samples were positive for the D test (double-disk diffusion test) (Figure 2). In the genotypic determination provided by PCR, it was observed that 25% of the samples presented the mecA gene, which characterizes the Methicillin Resistant S. aureus– MRSA. It is important to highlight that only two samples presented a phenotype resistant to Cefoxitin, although 3 samples (14.3%) presented the mecA , however it was not expressed because all the samples were sensitive. In the genotypic assessment of macrolides resistance profile for the amplification of the ermC gene and ermA, 5% of the samples were positive for ermA and 35% of the samples were positive for ermC. It was observed that in the genotypic test 2 samples (10%) presented the ermC gene, despite the positive sensitivity profile to Erythromycin.10% of the samples were positive for the presence of mecA and ermC genes (Figure 3).


Figure 1
A) Percentage frequency of sampled students according to the period; and B) percentage frequency of students who work in hospitals according to the period


Figure 2
Positive D – test. It is possible to observe the halo flattening forming latter ‘D’ aspect due to the induction by erythromycin

Table 1 shows that there was no significant difference (p > 0.05) between the proportions of resistant strains to antibiotics and the evaluated samples from different periods.

Furthermore, there was no significant difference (p > 0.05) between students working in hospitals and proportions of antibiotic resistant samples (Table 2).


Figure 3
lectrophoresis in 1.7% agarose gel with amplification of the gene: ermC (572 bp) bands 1 to 7, mecA (533 bp) band 1 to 5 and ermA gene (421 bp) band 1 and L as a marker

Table 1
Proportions of resistant samples to Erythromycin (ERI), Clindamycin (CLI), Oxacillin (OXA) e Cefoxitin (CFO) in the nursing students from the first (n = 8), s (n = 3) and third periods (n = 9)

Table 2
Proportions of samples resistant to the antibiotics Erythromycin, Clindamycin and Cefoxitin in students that work (n = 9) or not in hospitals (n = 11)

Table 3 shows there were no significant differences (p > 0.05) between the period (period) of students positive for the mecA gene, ermA, and ermC. There was also no significant difference (p > 0.05) between the positive results for the mecA gene, ermA, ermC and the fact of working in hospitals (Table 4).

Table 3
Proportions of positive samples to mecA, ermA and ermC in nursing students from the first (n = 8), s (n = 3) and third periods (n = 9)

Table 4
Proportions of resistant samples to the antibiotics Erythromycin, Clindamycin, Oxacillin and Cefoxitin in nursing students that work (n = 9) or not in hospitals (n = 11)

From 62 samples taken from students, 32.3% of the samples were positive for S. aureus. These data can be corroborated with the findings described by (Goldmann & Sands, 1992) who obtained an incidence rate of carriers of this microorganism between 30 to 40%, according to the author. Pereira and Cunha (2009) in their study of nasal colonization by Staphylococcus spp. resistant to Oxacillin in nursing students demonstrated a high rate of student carriers who had no prior contact to the hospital, which is consistent with the results obtained in this study, which observed 38% of positive samples for S. aureus in students from the first period, revealing that S. aureus is very present in the microbiota of people.

In the assessment of the phenotypic resistance, it was found that 32.3 and 6% (30%) samples were resistant to Erythromycin. These data differ from the findings of (Heshiki et al., 2002) who carried out the analysis of nasal colonization in resident doctors of the University hospital of Londrina (Paraná State), and which described that 19% of isolated samples showed high resistance to Erythromycin.

Among the 20 samples, 2 samples (10%) were resistant to Cefoxitin and 2 samples (10%) resistant to Oxacillin. The small number of samples found resistant to Cefoxitin and Oxacillin are consistent with the results observed by Pereira and Cunha (2009), where all the strains of S. aureus isolated from nursing students were susceptible to Oxacillin and Cefoxitin, suggesting that these bacteria are found in the community.

In the present study, all samples were sensitive to Clindamycin and only 1 sample (5%) presented an intermediate resistance profile. In the study of (Silva et al., 2012) regarding the colonization by S. aureus in the nursing staff from a teaching hospital in Pernambuco, it was reported that 11.9% of isolates were resistant to Clindamycin, differing from the results presented in this current paper. On the other hand, a study by Santos et al. (2007), which evaluated Staphylococcus aureus hospital importance, showed a sensitivity profile of 85-100% for Clindamycin, being similar to the results described in this study. Regarding to the evaluation of genotypic profile, 2 samples (10%) were positive for the mecA and ermC gene, characterizing a multidrug resistance profile. Coelho et al. (2007), conducted a mapping of resistance and detection of mecA gene profile of Staphylococcus aureus isolated from humans, which resulted in 12 (43%) of the samples with the presence of the mecA resistance gene out of 28 samples evaluated, thus indicating a higher potential.

According to these authors the increased strains of S. aureus resistant to methicillin (MRSA) is possibly favored due to the transfer of the mecA gene among the strains of Staphylococcus spp. in conjunction with the selective pressure derived from the indiscriminate use of antimicrobials. According to Coutinho et al. (2010) study on the evaluation of the prevalence of erm genes inducible to Clindamycin in Staphylococcus aureus isolates from patients treated at the Clinical Hospital of Porto Alegre, it was shown that from 94 positive samples for S. aureus, 46.9% presented ermA, results that disagree with the results obtained in this study, where it was observed 5% of positive samples for ermA was observed. Moreover, according to Coutinho et al. (2010), 29.8% of the positive samples for ermC gene were observed, corroborating the findings of this present study, where 33.3% of S. aureus samples were positive for the gene.

Conclusion

Considering the results, it can be concluded that students related to any health-care, such as nursing students, may be colonized with S. aureus with multidrug resistance potential. The monitoring of students and professionals linked to health-care, which attend the hospital environment, along with hygiene measures are essential to prevent and control the spread of these infectious agents, especially the more resistant strains.

Supplementary material
References
Archer, G. L., & Climo, M. W. (1998). Staphylococcus aureus: a well-armed pathogen. Clinical Infectious Diseases, 26(n. 5), 1179-1181.
Barrett, J. F. (2005). MRSA – what is it, and how do we deal with the problem? Expert Opinion on Therapeutic Targets, 9(2), 253-265.
Bohach, G. A., Fast, D. J., Nelson, R. D., & Schlievert, P. M. (1990). Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Critical Reviews in Microbiology, 17(4), 251-272.
Clinical and Laboratory Standards Institute [CLSI]. (2011). Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement M100-S20, 30(1), 2011.
Coelho, S. D. M. D. O., Moraes, R. A. M., Soares, L. D. C., Pereira, I. A., Gomes, L. P., & Souza, M. M. S. (2007). Mapeamento do perfil de resistência e detecção do gene mecA em Staphylococcus aureus e Staphylococcus intermedius oxacilina-resistentes isolados de espécies humanas e animais. Ciência Rural, 37(1), 195-200.
Corso, A., Sanches, I. S., Sousa, M. A., Rossi, A., & Lencastre, H. (1998). Spread of a methicillin-resistant and multiresistant epidemic clone of Staphylococcus aureus in Argentina. Microbial Drug Resistance, 4(4), 277-288.
Coutinho, V. D. L. S., Paiva, R. M., Reiter, K. C., Paris, F., Barth, A. L., & Machado, A. B. M. P. (2010). Distribution of erm genes and low prevalence of inducible resistance to clindamycin among staphylococci isolates. Brazilian Journal of Infectious Diseases, 14(6), 564-568.
Deresinski, S. (2005). Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 40(4), 562-573.
Dinges, M. M., Orwin, P. M., & Schlievert, P. M. (2000). Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews, 13(1), 16-34.
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., & Spratt, B. G. (2002). The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proceedings of the National Academy of Sciences of the United States of America, 99(11), 7687-7692.
Finch, R. (2006). Gram-positive infections: lessons learnt and novel solutions. Clinical Microbiology and Infection, 12(s8), 3-8.
Fitzgerald, J. R., Sturdevant, D. E., Mackie, S. M., Gill, S. R., & Musser, J. M. (2001). Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proceedings of the National Academy of Sciences of the United States of America, 98(15), 8821-8826.
Foster, T. J. (2005). Immune evasion by staphylococci. Nature Review Microbiology, 3(12), 948-958.
Gardella, N., Picasso, R., Predari, S. C., Lasala, M., Foccoli, M., Benchetrit, G., … Gutkind, G. (2005). Methicillin-resistant Staphylococcus aureus strains in Buenos Aires Teaching Hospitals: Replacement of the multidrug resistant South American clone by another susceptible to rifampin, minocycline and trimethoprim- sulfamethoxazole. Revista Argentina de Microbiologia, 37(3), 156-160.
Goldmann, D. A., & Sands, K. E. F. (1992). Epidemiology of Staphylococcus aureus and Group-A streptococci. Hospital Infections, Brown Little, 767-787.
Hanssen, A.-M., & Sollid, J. U. E. (2006). SCC mec in staphylococci: genes on the move. FEMS Immunology & Medical Microbiology, 46(1), 8-20.
Heshiki, Z., Quesada, R. M. B., Heshiki, R. E., Joaquim, D. M., & Brandão, L. G. (2002). Flora bacteriana nasal: estudo entre médicos residentes dos Hospitais Universitários de Londrina - Brasil. Semina Ciencias Biológicas e Saude, 23(1), 3-10.
Hiramatsu, K., Cui, L., Kuroda, M., & Ito, T. (2001). The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends in Microbiology, 9(10), 486-493.
Ito, T., Okuma, K., Ma, X. X., Yuzawa, H., & Hiramatsu, K. (2003). Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resistance Updates, 6(1), 41-52.
Ladhani, S., Joannou, C. L., Lochrie, D. P., Evans, R. W., & Poston, S. M. (1999). Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clinical Microbiology Reviews, 12(2), 224-242.
Le Loir, Y., Baron, F., & Gautier, M. (2003). Staphylococcus aureus and food poisoning. Genetic Molecular Research, 2(1), 63-76.
McCulloch, J. A. (2006). Avaliação da funcionalidade do locus accessory gene regulator (agr) em cepas de Staphylococcus aureus brasileiras com sensibilidade reduzida aos glicopeptídeos. São Paulo, SP: Faculdade de Ciências Farmacêuticas.
Mkrtchyan, H. V., Xu, Z., & Cutler, R. R. (2015). Diversity of SCCmec elements in Staphylococci isolated from public washrooms. BMC Microbiology, 15(120), 2-5.
Muto, C. A., Jernigan, J. A., Ostrowsky, B. E., Richet, H. M., Jarvis, W. R., Boyce, J. M., & Farr, B. M. (2003). SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infection Control and Hospital Epidemiology : The Official Journal of the Society of Hospital Epidemiologists of America, 24(5), 362-386.
Naimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., … Cheek, J. E. (2001). Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clinical Infectious Diseases, 33(7), 990-996.
Oliveira, G. A., Faria, J. B., Levyand, C. E., & Mamizuka, E. M. (2001). Characterization of the Brazilian endemic clone of methicillin-resistant Staphylococcus aureus (MRSA) from hospitals throughout Brazil. Brazilian Journal of Infectious Diseases, 5(4), 163-170.
Pannuti, C. S., & Grinbaum, R. S. (1995). An overview of nosocomial infection control in Brazil. Infection Control, 16(3), 170-174.
Pereira, E. P. L., & Cunha, M. D. L. R. D. S. D. (2009). Avaliação da colonização nasal por Staphylococcus spp. Resistente à oxacilina em alunos de enfermagem. Jornal Brasileiro de Patologia e Medicina Laboratorial, 45(5), 361-369.
Rajana, V., Schoenfelderb, S. M. K., Ziebuhrb, W., & Gopal, S. (2015). Genotyping of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) in a tertiary care centre in Mysore, South India: ST2371-SCCmec IV emerges as the major clone. Infection, Genetics and Evolution, 34, 230-235.
Sader, H. S., Pignatari, A. C., Hollis, R. J., Leme, I., & Jones, R. N. (1993). Oxacillin-and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study. Infection Control, 14(5), 260-264.
Santos, A. L., Santos, D. O., Freitas, C. C., Ferreira, B. L. A., Afonso, I. F., Rodrigues, C. R., & Castro, H. C. (2007). Staphylococcus aureus: visitando uma cepa de importância hospitalar. Jornal Brasileiro de Patologia e Medicina Laboratorial, 43(6), 413-423.
Seas, C., Hernandez, K., Ramos, R., Bazan, E., Rodriguez, I., Torres, A., … Gotuzzo, E. (2006). Oxacillin‐ resistant and multidrug‐resistant Staphylococcus aureus in Lima, Peru. Infection Control and Hospital Epidemiology, 27(2), 198-200.
Silva, E. C. B. F., Samico, T. M., Cardoso, R. R., Rabelo, M. A., Bezerra Neto, A. M., Melo, F. L., … Maciel, M. A. V. (2012). Colonization by Staphylococcus aureus among the nursing staff of a teaching hospital in Pernambuco. Revista da Escola de Enfermagem da USP, 46(1), 132-137.
Teixeira, L. A., Resende, C. A., Ormonde, L. R., Rosenbaum, R., Figueiredo, A. M. S., Lencastre, H., & Tomasz, A. (1995). Geographic spread of epidemic multiresistant Staphylococcus aureus clone in Brazil. Journal of Clinical Microbiology, 33(9), 2400-2404.
Vivoni, A. M., Diep, B. A., Magalhães, A. C. G., Santos, K. R. N., Riley, L. W., Sensabaugh, G. F., & Moreira, B. M. (2006). Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital: identification of international circulating lineages. Journal of Clinical Microbiology, 44(5), 1686-1691.
Notes
Author notes

marcusvinicius@unoeste.br


Figure 1
A) Percentage frequency of sampled students according to the period; and B) percentage frequency of students who work in hospitals according to the period

Figure 2
Positive D – test. It is possible to observe the halo flattening forming latter ‘D’ aspect due to the induction by erythromycin

Figure 3
lectrophoresis in 1.7% agarose gel with amplification of the gene: ermC (572 bp) bands 1 to 7, mecA (533 bp) band 1 to 5 and ermA gene (421 bp) band 1 and L as a marker
Table 1
Proportions of resistant samples to Erythromycin (ERI), Clindamycin (CLI), Oxacillin (OXA) e Cefoxitin (CFO) in the nursing students from the first (n = 8), s (n = 3) and third periods (n = 9)

Table 2
Proportions of samples resistant to the antibiotics Erythromycin, Clindamycin and Cefoxitin in students that work (n = 9) or not in hospitals (n = 11)

Table 3
Proportions of positive samples to mecA, ermA and ermC in nursing students from the first (n = 8), s (n = 3) and third periods (n = 9)

Table 4
Proportions of resistant samples to the antibiotics Erythromycin, Clindamycin, Oxacillin and Cefoxitin in nursing students that work (n = 9) or not in hospitals (n = 11)

Buscar:
Contexto
Descargar
Todas
Imágenes
Scientific article viewer generated from XML JATS4R by Redalyc